ArticleJournal of translational medicine2025

Real-world evidence for repurposing hydralazine as a potential epigenetic modulator for psoriasis: a 16-year retrospective nationwide cohort study.

Shou-En Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.